Symbols / FEED $1.82 -3.19%
FEED Chart
About
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. The company's product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. It also provides UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. The company was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025. ENvue Medical, Inc. was incorporated in 2003 and is based in Tyler, Texas.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 1.98M |
| Enterprise Value | -1.73M | Income | -4.58M | Sales | 2.69M |
| Book/sh | 42.00 | Cash/sh | 6.39 | Dividend Yield | — |
| Payout | 0.00% | Employees | 31 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.74 | P/B | 0.04 | P/C | — |
| EV/EBITDA | 0.20 | EV/Sales | -0.65 | Quick Ratio | 0.62 |
| Current Ratio | 0.86 | Debt/Eq | 7.46 | LT Debt/Eq | — |
| EPS (ttm) | -51.81 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | 92.00% | Earnings | 2019-11-19 17:00 | ROA | -19.99% |
| ROE | -30.51% | ROIC | — | Gross Margin | 30.02% |
| Oper. Margin | -3.11% | Profit Margin | -251.92% | Shs Outstand | 1.09M |
| Shs Float | 848.15K | Short Float | 32.23% | Short Ratio | 0.01 |
| Short Interest | — | 52W High | 162.50 | 52W Low | 0.99 |
| Beta | 2.28 | Avg Volume | 10.40M | Volume | 76.85K |
| Target Price | — | Recom | None | Prev Close | $1.88 |
| Price | $1.82 | Change | -3.19% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$1.82
Latest analyst target
3. DCF / Fair value
$10.95
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.82
Low
—
High
—
Mean
—
- $FEED stock is up 15% today. Here's what we see in our data. - Quiver Quantitative Fri, 06 Mar 2026 19
- Fueling RNG: Key Provisions and Practical Considerations in Feedstock Supply Agreements - JD Supra Fri, 06 Mar 2026 17
- FEED Stock Price, News & Analysis - Stock Titan ue, 16 Dec 2025 02
- PNNL Strengthens U.S. Supply of Key Feedstock for Quantum Technologies | Newswise - Newswise Fri, 06 Mar 2026 00
- Why Is FEED Stock Soaring Over 130% Today? - Stocktwits Wed, 28 Jan 2026 08
- Feedstock Shock: Asian Petrochemical Plants Slash Output - ChemAnalyst Mon, 09 Mar 2026 14
- DOE delivers HALEU feedstock for advanced reactor fuel - World Nuclear News hu, 08 Jan 2026 08
- Biomass: An Energy Resource | Department of Energy - Department of Energy (.gov) hu, 22 Jan 2026 23
- Feedstock Supply Crunch Adds to European Biofuels Volatility - CME Group ue, 02 Dec 2025 08
- Winter Oilseeds as a Response to Biofuels Feedstock Demand - farmdoc daily ue, 23 Dec 2025 08
- Corteva and bp launch biofuel feedstock joint venture Etlas™ | News and insights | Home - BP Wed, 07 Jan 2026 08
- FEED Stock Tumbles as Recent Financial Reports Raise Concerns - StocksToTrade Wed, 14 Jan 2026 08
- European biofuel feedstock prices fluctuate significantly in 2025, market expects more volatility next year: 2026 preview - Fastmarkets Mon, 26 Jan 2026 08
- Reusable tube-feeding syringes head to US homes in ENvue–U-Deliver deal - Stock Titan Wed, 28 Jan 2026 08
- $FEED stock is up 12% today. Here's what we see in our data. - Quiver Quantitative Mon, 09 Feb 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 2918 | 7062 | — | Sale at price 2.42 per share. | BANK OF AMERICA CORPORATION | Beneficial Owner of more than 10% of a Class of Security | — | 2026-02-02 00:00:00 | I |
| 1 | 240000 | 408000 | — | Purchase at price 1.70 per share. | GLIBERT CHRISTIAN MICHAEL | Beneficial Owner of more than 10% of a Class of Security | — | 2026-01-14 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | -2.30M |
| TaxRateForCalcs | 0.21 | 0.00 | 0.21 | 0.27 |
| NormalizedEBITDA | -3.55M | -3.55M | -5.07M | -5.73M |
| TotalUnusualItems | 0.00 | -8.52M | ||
| TotalUnusualItemsExcludingGoodwill | 0.00 | -8.52M | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -3.71M | -3.71M | -5.45M | -14.28M |
| ReconciledDepreciation | 1.00K | 1.00K | 1.00K | 2.00K |
| ReconciledCostOfRevenue | 1.05M | 746.00K | 585.00K | 925.00K |
| EBITDA | -3.55M | -3.55M | -5.07M | -14.25M |
| EBIT | -3.55M | -3.55M | -5.07M | -14.25M |
| NetInterestIncome | -104.00K | -246.00K | -401.00K | -48.00K |
| InterestExpense | 135.00K | 135.00K | 347.00K | 0.00 |
| NormalizedIncome | -3.71M | -3.71M | -5.45M | -8.06M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -3.71M | -3.71M | -5.45M | -14.28M |
| TotalExpenses | 6.14M | 5.72M | 5.76M | 7.38M |
| TotalOperatingIncomeAsReported | -3.58M | -3.44M | -5.01M | -5.68M |
| DilutedAverageShares | 26.98K | 15.91K | 12.91K | 11.44K |
| BasicAverageShares | 26.98K | 15.91K | 12.91K | 11.44K |
| DilutedEPS | -137.30 | -233.20 | -422.40 | -1.25K |
| BasicEPS | -137.30 | -233.20 | -422.40 | -1.25K |
| DilutedNIAvailtoComStockholders | -3.71M | -3.71M | -5.45M | -14.28M |
| NetIncomeCommonStockholders | -3.71M | -3.71M | -5.45M | -14.28M |
| NetIncome | -3.71M | -3.71M | -5.45M | -14.28M |
| NetIncomeIncludingNoncontrollingInterests | -3.71M | -3.71M | -5.45M | -14.28M |
| NetIncomeContinuousOperations | -3.71M | -3.71M | -5.45M | -14.28M |
| TaxProvision | 19.00K | 29.00K | 35.00K | 32.00K |
| PretaxIncome | -3.69M | -3.68M | -5.41M | -14.25M |
| OtherIncomeExpense | -8.52M | |||
| OtherNonOperatingIncomeExpenses | -1.63M | |||
| SpecialIncomeCharges | 0.00 | -1.63M | ||
| OtherSpecialCharges | 1.63M | |||
| GainOnSaleOfSecurity | -6.89M | |||
| NetNonOperatingInterestIncomeExpense | -104.00K | -246.00K | -401.00K | -48.00K |
| TotalOtherFinanceCost | -31.00K | 111.00K | 54.00K | 48.00K |
| InterestExpenseNonOperating | 135.00K | 135.00K | 347.00K | 0.00 |
| OperatingIncome | -3.58M | -3.44M | -5.01M | -5.68M |
| OperatingExpense | 5.09M | 4.97M | 5.18M | 6.45M |
| ResearchAndDevelopment | 909.00K | 185.00K | 283.00K | 293.00K |
| SellingGeneralAndAdministration | 4.18M | 4.79M | 4.90M | 6.16M |
| SellingAndMarketingExpense | 720.00K | 864.00K | 965.00K | 1.10M |
| GeneralAndAdministrativeExpense | 3.46M | 3.92M | 3.93M | 5.06M |
| OtherGandA | 3.46M | 3.92M | 3.93M | 5.06M |
| GrossProfit | 1.51M | 1.54M | 167.00K | 770.00K |
| CostOfRevenue | 1.05M | 746.00K | 585.00K | 925.00K |
| TotalRevenue | 2.56M | 2.28M | 752.00K | 1.70M |
| OperatingRevenue | 2.56M | 2.28M | 752.00K | 1.70M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 37.89K | 18.60K | 14.92K | 12.73K |
| ShareIssued | 378.94K | 18.60K | 14.92K | 127.26K |
| TotalDebt | 116.00K | 5.00K | 81.00K | 49.00K |
| TangibleBookValue | 627.00K | 3.99M | 3.23M | 6.31M |
| InvestedCapital | 627.00K | 3.99M | 3.23M | 6.31M |
| WorkingCapital | 609.00K | 4.03M | 3.29M | 6.44M |
| NetTangibleAssets | 627.00K | 3.99M | 3.23M | 6.31M |
| CapitalLeaseObligations | 116.00K | 5.00K | 81.00K | 49.00K |
| CommonStockEquity | 627.00K | 3.99M | 3.23M | 6.31M |
| TotalCapitalization | 627.00K | 3.99M | 3.23M | 6.31M |
| TotalEquityGrossMinorityInterest | 627.00K | 3.99M | 3.23M | 6.31M |
| StockholdersEquity | 627.00K | 3.99M | 3.23M | 6.31M |
| GainsLossesNotAffectingRetainedEarnings | -80.00K | -67.00K | -18.00K | 60.00K |
| OtherEquityAdjustments | -80.00K | -67.00K | -18.00K | 60.00K |
| RetainedEarnings | -69.80M | -66.10M | -62.38M | -56.94M |
| AdditionalPaidInCapital | 70.50M | 70.15M | 65.63M | 63.19M |
| CapitalStock | 3.00K | 2.00K | 2.00K | 1.00K |
| CommonStock | 3.00K | 2.00K | 2.00K | 1.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 3.00M | 2.69M | 2.65M | 2.31M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 280.00K | 232.00K | 330.00K | 406.00K |
| DerivativeProductLiabilities | 0.00 | |||
| EmployeeBenefits | 216.00K | 217.00K | 223.00K | 253.00K |
| NonCurrentPensionAndOtherPostretirementBenefitPlans | 216.00K | 217.00K | 223.00K | 253.00K |
| NonCurrentDeferredLiabilities | 0.00 | 15.00K | 107.00K | 153.00K |
| NonCurrentDeferredRevenue | 0.00 | 15.00K | 107.00K | 153.00K |
| LongTermDebtAndCapitalLeaseObligation | 64.00K | 0.00 | 0.00 | |
| LongTermCapitalLeaseObligation | 64.00K | 0.00 | 0.00 | |
| CurrentLiabilities | 2.72M | 2.45M | 2.32M | 1.90M |
| CurrentDeferredLiabilities | 15.00K | 46.00K | 21.00K | 44.00K |
| CurrentDeferredRevenue | 15.00K | 46.00K | 21.00K | 44.00K |
| CurrentDebtAndCapitalLeaseObligation | 52.00K | 5.00K | 81.00K | 49.00K |
| CurrentCapitalLeaseObligation | 52.00K | 5.00K | 81.00K | 49.00K |
| PayablesAndAccruedExpenses | 2.65M | 2.40M | 2.21M | 1.81M |
| Payables | 2.65M | 2.40M | 2.21M | 1.81M |
| OtherPayable | 2.61M | 2.27M | 2.15M | 1.72M |
| AccountsPayable | 47.00K | 138.00K | 66.00K | 87.00K |
| TotalAssets | 3.63M | 6.67M | 5.88M | 8.62M |
| TotalNonCurrentAssets | 298.00K | 187.00K | 270.00K | 280.00K |
| OtherNonCurrentAssets | 1.00K | 3.00K | 19.00K | |
| DefinedPensionBenefit | 173.00K | 174.00K | 179.00K | 207.00K |
| NetPPE | 125.00K | 12.00K | 88.00K | 54.00K |
| GrossPPE | 125.00K | 12.00K | 88.00K | 54.00K |
| OtherProperties | 125.00K | 12.00K | 88.00K | 54.00K |
| CurrentAssets | 3.33M | 6.49M | 5.61M | 8.34M |
| RestrictedCash | 0.00 | |||
| PrepaidAssets | 120.00K | 47.00K | 612.00K | 166.00K |
| Inventory | 2.19M | 2.73M | 2.17M | 175.00K |
| FinishedGoods | 1.80M | 2.52M | 2.15M | 175.00K |
| RawMaterials | 391.00K | 210.00K | 30.00K | 0.00 |
| Receivables | 268.00K | 425.00K | 109.00K | 264.00K |
| OtherReceivables | 170.00K | 107.00K | 100.00K | 64.00K |
| AccountsReceivable | 98.00K | 318.00K | 9.00K | 200.00K |
| CashCashEquivalentsAndShortTermInvestments | 752.00K | 3.28M | 2.71M | 7.74M |
| CashAndCashEquivalents | 752.00K | 3.28M | 2.71M | 7.74M |
| CashFinancial | 752.00K | 3.28M | 2.71M | 7.74M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -2.52M | -3.60M | -7.04M | -4.37M |
| RepaymentOfDebt | 0.00 | |||
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 0.00 | 4.21M | 2.09M | 0.00 |
| CapitalExpenditure | -3.00K | -1.00K | -3.00K | -3.00K |
| InterestPaidSupplementalData | 0.00 | 0.00 | 0.00 | |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | |
| EndCashPosition | 752.00K | 3.28M | 2.71M | 7.74M |
| BeginningCashPosition | 3.28M | 2.71M | 7.74M | 7.53M |
| EffectOfExchangeRateChanges | -13.00K | -49.00K | -78.00K | -6.00K |
| ChangesInCash | -2.52M | 619.00K | -4.95M | 210.00K |
| FinancingCashFlow | 1.00K | 4.22M | 2.09M | 4.58M |
| CashFlowFromContinuingFinancingActivities | 1.00K | 4.22M | 2.09M | 4.58M |
| ProceedsFromStockOptionExercised | 1.00K | 7.00K | 2.00K | 4.58M |
| NetCommonStockIssuance | 0.00 | 4.21M | 2.09M | 0.00 |
| CommonStockIssuance | 0.00 | 4.21M | 2.09M | 0.00 |
| NetIssuancePaymentsOfDebt | 0.00 | |||
| NetLongTermDebtIssuance | 0.00 | |||
| LongTermDebtPayments | 0.00 | |||
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -3.00K | -1.00K | -3.00K | -3.00K |
| CashFlowFromContinuingInvestingActivities | -3.00K | -1.00K | -3.00K | -3.00K |
| NetPPEPurchaseAndSale | -3.00K | -1.00K | -3.00K | -3.00K |
| PurchaseOfPPE | -3.00K | -1.00K | -3.00K | -3.00K |
| OperatingCashFlow | -2.52M | -3.60M | -7.04M | -4.37M |
| CashFlowFromContinuingOperatingActivities | -2.52M | -3.60M | -7.04M | -4.37M |
| ChangeInWorkingCapital | 731.00K | -322.00K | -2.31M | -494.00K |
| ChangeInOtherWorkingCapital | -46.00K | -67.00K | -69.00K | -2.00K |
| ChangeInPayablesAndAccruedExpense | 151.00K | 53.00K | 55.00K | -324.00K |
| ChangeInAccruedExpense | 0.00 | -1.00K | -2.00K | 0.00 |
| ChangeInPayable | 151.00K | 54.00K | 57.00K | -324.00K |
| ChangeInAccountPayable | -91.00K | 72.00K | -21.00K | -59.00K |
| ChangeInInventory | 541.00K | -557.00K | -2.00M | -30.00K |
| ChangeInReceivables | 85.00K | 249.00K | -291.00K | -138.00K |
| ChangesInAccountReceivables | 221.00K | -309.00K | 191.00K | -175.00K |
| OtherNonCashItems | 101.00K | 135.00K | 347.00K | 1.50M |
| StockBasedCompensation | 356.00K | 293.00K | 354.00K | 382.00K |
| UnrealizedGainLossOnInvestmentSecurities | 0.00 | 2.00K | 16.00K | 6.00K |
| DepreciationAmortizationDepletion | 1.00K | 1.00K | 1.00K | 2.00K |
| DepreciationAndAmortization | 1.00K | 1.00K | 1.00K | 2.00K |
| OperatingGainsLosses | 8.52M | |||
| GainLossOnInvestmentSecurities | 8.52M | |||
| NetIncomeFromContinuingOperations | -3.71M | -3.71M | -5.45M | -14.28M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for FEED
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|